You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

68ga-psma-11

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Beijing (68Ga-P16-093, 68Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 1, 2022

Prostate Cancer Metastatic Trial in Peking (68Ga-PSMA-11, 68Ga-P15-041)

Recruiting
  • Prostate Cancer Metastatic
  • Peking, China
    Peking Union Medical College Hospital
Nov 25, 2022

Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,

Not yet recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • +2 more
  • 68Ga-PSMA-11
  • PET/CT or PET/MRI
  • Changsha, China
  • +5 more
Apr 26, 2023

Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent Trial in Dallas (68Ga-PSMA-11, Positron Emission

Available
  • Prostate Cancer
  • +2 more
  • 68Ga-PSMA-11
  • Positron Emission Tomography/Computed Tomography
  • Dallas, Texas
    UT Southwestern Medical Center
Sep 27, 2022

Prostate Cancer Trial in Stanford (68Ga RM2, 68Ga-PSMA-11, Investigational PET scanner coils and software)

Suspended
  • Prostate Cancer
  • 68Ga RM2
  • +2 more
  • Stanford, California
    Stanford University
May 3, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • 68Ga-PSMA-11
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California San Francisco
Feb 27, 2022

Prostate Adenocarcinoma Trial (68Ga-PSMA-11)

Available
  • Prostate Adenocarcinoma
  • 68Ga-PSMA-11
  • (no location specified)
Jun 10, 2022

Prostatic Tumor, Prostatic Cancer Trial in Vancouver (68Ga-PSMA-11)

Recruiting
  • Prostatic Neoplasm
  • Prostatic Cancer
  • 68Ga-PSMA-11
  • Vancouver, British Columbia, Canada
    BC Cancer
Feb 2, 2022

Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging

Completed
Has Results
  • Stage II Prostate Adenocarcinoma
  • Stage III Prostate Adenocarcinoma
  • 68Ga-PSMA-11
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Mar 2, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 16, 2023

Prostate Adenocarcinoma, PSA Failure, Recurrent Prostate Carcinoma Trial in Palo Alto (Computed Tomography (CT) scan,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Computed Tomography (CT) scan
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jan 6, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, Best supportive/best standard of care

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 2, 2023

Prostate Cancer, Positron-Emission Tomography Trial in Fuzhou (68Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • Positron-Emission Tomography
  • 68Ga-PSMA-11
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Apr 2, 2021

Prostate Cancer Trial in San Francisco (CTT1403, CTT1057, 68Ga-PSMA-11)

Active, not recruiting
  • Prostate Cancer
  • San Francisco, California
    University of California, San Francisco
Apr 14, 2022

Prostate Cancer Trial in Boston, Brooklyn, New York (225Ac-J591, Pembrolizumab, Androgen receptor pathway inhibitor)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +3 more
Sep 20, 2021